An Open Label Evaluation of the Dose Proportionality of Dilaudid SR (OROS Hydromorphone HCL) Tablets 8mg, 16mg, 32mg, and 64mg.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors ALZA Corporation
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Nov 2006 New trial record.